Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,966.00
-10.00 (-0.51%)
At close: Dec 5, 2025

Yungjin Pharm. Revenue

Yungjin Pharm. had revenue of 38.98B KRW in the quarter ending September 30, 2013, with 4.67% growth. This brings the company's revenue in the last twelve months to 158.79B, up 23.36% year-over-year. In the year 2012, Yungjin Pharm. had annual revenue of 137.69B with 22.82% growth.

Revenue (ttm)
158.79B
Revenue Growth
+23.36%
P/S Ratio
2.26
Revenue / Employee
276.63M
Employees
574
Market Cap
359.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2012137.69B25.58B22.82%
Dec 31, 2011112.11B-4.21B-3.62%
Dec 31, 2010116.32B12.94B12.52%
Dec 31, 2009103.38B-7.53B-6.79%
Dec 31, 2008110.91B1.25B1.14%
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Dec 31, 2004 Pro Pro Pro
Dec 31, 1999 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 5,504.84B
Celltrion 3,895.99B
ALTEOGEN 202.18B
ABL Bio 88.44B
SK Biopharmaceuticals 675.41B
Yuhan 2,136.67B
LigaChem Biosciences 159.27B
Peptron 6.19B
Revenue Rankings